Medication-related osteonecrosis of the jaw (Q67496): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Deve-se suspeitar ONMRM (osteonecrose da mandíbula relacionada a medicamentos) em pacientes que apresentam todas as características a seguir: _x000D_ 1. Uso atual ou prévio de medicamentos antirreabsortivos ou antiangiogênicos;_x000D_ 2. Osso exposto ou osso que pode ser sondado através de fístula(s) intraoral(ais) ou extraoral(ais) na região maxilofacial que persiste por mais de oito semanas;_x000D_ 3. Ausência de história de radioterapia em mandíbulas ou de óbvia doença mestastática para mandíbulas | |||
| description / en | description / en | ||
Patients may be considered to have MRONJ (medication-related osteonecrosis of the jaw) if all of the following characteristics are present: 1. Current or previous treatment with antire-sorptive or antiangiogenic agents; 2. Exposed bone or bone that can be probed through an intraoral or extraoral fistula(e) in the maxillofacial region that has persisted for more than eight weeks; 3. No history of radiation therapy to the jaws or obvious metastatic disease to the jaws. | |||
Revision as of 15:19, 14 August 2026
Patients may be considered to have MRONJ (medication-related osteonecrosis of the jaw) if all of the following characteristics are present: 1. Current or previous treatment with antire-sorptive or antiangiogenic agents; 2. Exposed bone or bone that can be probed through an intraoral or extraoral fistula(e) in the maxillofacial region that has persisted for more than eight weeks; 3. No history of radiation therapy to the jaws or obvious metastatic disease to the jaws.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1143080357 |
||
| English | Medication-related osteonecrosis of the jaw |
Patients may be considered to have MRONJ (medication-related osteonecrosis of the jaw) if all of the following characteristics are present: 1. Current or previous treatment with antire-sorptive or antiangiogenic agents; 2. Exposed bone or bone that can be probed through an intraoral or extraoral fistula(e) in the maxillofacial region that has persisted for more than eight weeks; 3. No history of radiation therapy to the jaws or obvious metastatic disease to the jaws. |
